FR2614789B1 - Emploi en therapeutique des agonistes des recepteurs de la dopamine pour le traitement de la dependance a la nicotine - Google Patents

Emploi en therapeutique des agonistes des recepteurs de la dopamine pour le traitement de la dependance a la nicotine

Info

Publication number
FR2614789B1
FR2614789B1 FR888805957A FR8805957A FR2614789B1 FR 2614789 B1 FR2614789 B1 FR 2614789B1 FR 888805957 A FR888805957 A FR 888805957A FR 8805957 A FR8805957 A FR 8805957A FR 2614789 B1 FR2614789 B1 FR 2614789B1
Authority
FR
France
Prior art keywords
treatment
receptor agonists
therapeutic use
dopamine receptor
nicotine dependence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR888805957A
Other languages
English (en)
French (fr)
Other versions
FR2614789A1 (fr
Inventor
Peter S Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2614789A1 publication Critical patent/FR2614789A1/fr
Application granted granted Critical
Publication of FR2614789B1 publication Critical patent/FR2614789B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR888805957A 1987-05-07 1988-05-02 Emploi en therapeutique des agonistes des recepteurs de la dopamine pour le traitement de la dependance a la nicotine Expired - Lifetime FR2614789B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4775387A 1987-05-07 1987-05-07

Publications (2)

Publication Number Publication Date
FR2614789A1 FR2614789A1 (fr) 1988-11-10
FR2614789B1 true FR2614789B1 (fr) 1991-10-18

Family

ID=21950776

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888805957A Expired - Lifetime FR2614789B1 (fr) 1987-05-07 1988-05-02 Emploi en therapeutique des agonistes des recepteurs de la dopamine pour le traitement de la dependance a la nicotine

Country Status (13)

Country Link
JP (1) JPS63287723A (de)
KR (1) KR880013556A (de)
AU (1) AU622614B2 (de)
CH (1) CH675834A5 (de)
DE (1) DE3814521A1 (de)
DK (1) DK245388A (de)
FR (1) FR2614789B1 (de)
GB (1) GB2204240B (de)
IT (1) IT1219564B (de)
NL (1) NL8801171A (de)
PH (1) PH25495A (de)
SE (1) SE8801708L (de)
ZA (1) ZA883237B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR861128B (en) * 1985-05-06 1986-08-26 Sandoz Ag New use of dopamine agonists
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin

Also Published As

Publication number Publication date
GB2204240A (en) 1988-11-09
PH25495A (en) 1991-07-24
AU622614B2 (en) 1992-04-16
KR880013556A (ko) 1988-12-21
SE8801708L (sv) 1988-11-08
DK245388D0 (da) 1988-05-05
SE8801708D0 (sv) 1988-05-05
IT8847906A0 (it) 1988-05-03
FR2614789A1 (fr) 1988-11-10
AU1560588A (en) 1988-11-10
ZA883237B (en) 1990-01-31
GB2204240B (en) 1991-04-24
DK245388A (da) 1988-11-08
CH675834A5 (de) 1990-11-15
IT1219564B (it) 1990-05-18
JPS63287723A (ja) 1988-11-24
GB8810509D0 (en) 1988-06-08
NL8801171A (nl) 1988-12-01
DE3814521A1 (de) 1988-11-17

Similar Documents

Publication Publication Date Title
FR2619003B1 (fr) Appareil ultrasonore de traitement therapeutique
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE876157Q (fr) Medicament pour le traitement de l'acne
IT1219906B (it) Impieghi in terapeutica degli agonisti dei recettori dopaminergici
BE869152A (fr) Dispositif pour le traitement de la surface de corps presentant des contours irreguliers
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2510889B1 (fr) Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau
FR2614789B1 (fr) Emploi en therapeutique des agonistes des recepteurs de la dopamine pour le traitement de la dependance a la nicotine
BE891987A (fr) Composition pharmaceutique pour le traitement des maladies de la cavite buccale
FR2587213B1 (fr) Medicament pour le traitement de la dependance aux psychostimulants
BE871753A (fr) Nouvelle utilisation therapeutique de l'acetyl-1-carnitine pour le traitement des affections cardiaques
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE856957A (fr) Electrode pour traitement d'ionophorese
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE882635A (fr) Appareil d'hydrotherapie, en particulier pour le traitement des algies vertebrales
BE895861A (fr) Agent therapeutique pour le traitement de troubles allergiques, de maladies a complexes immunitaires et de tumeurs
BE868593A (fr) Alpha-vinyl-amino-acides, leur obtention et leur utilisation pour le traitement de la maladie de parkinson et d'etats depressifs
PT66619B (fr) Procede pour la preparation de verbenone myrthenal et pinocarveolo et son emploi therapeutique
ZA886656B (en) Device for treatment of gum disease
RO86562A2 (ro) Compozitie vegetala medicamentoasa pentru tratarea unor afectiuni hepato-biliare
FR2310767A1 (fr) Medicament pour le traitement de l'alopecia chronica diffusa
BE860239A (fr) Preparation medicinale pour le traitement des neoformations malignes
GB8810732D0 (en) Ocular self-treatment device
BE881640A (fr) Nouveaux medicament pour le traitement de l'obesite

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse
TP Transmission of property